Limbach’s shares dropped sharply by 35% as investors reacted negatively to organic revenue decline, continued margin compression, and cautious outlook despite strong bookings and stable adjusted EBITDA.

• First quarter revenue grew 4.3% to $138.9 million but organic revenue fell 13.4%, reflecting prior booking softness and seasonal weakness.
• ODR segment revenue increased 10.4%, yet organic ODR revenue declined 5.4%; gross margin contracted to 22.4% due to lower fixed cost absorption and absence of prior year project write-ups.
• Adjusted EBITDA of $8.7 million met expectations, but cash flow was negative due to lower net income and elevated working capital needs.
• Bookings were robust at $209 million with a 1.5x book-to-bill ratio, driven by strength in data centers (27% of bookings) and health care verticals.
• Management emphasized strategic investments in sales enablement, vertical market teams, and customer solution offerings but provided a guarded outlook amid organic growth headwinds and margin pressure.